Correlation Between SAB Biotherapeutics and Cyclerion Therapeutics
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Cyclerion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Cyclerion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Cyclerion Therapeutics, you can compare the effects of market volatilities on SAB Biotherapeutics and Cyclerion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Cyclerion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Cyclerion Therapeutics.
Diversification Opportunities for SAB Biotherapeutics and Cyclerion Therapeutics
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SAB and Cyclerion is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Cyclerion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclerion Therapeutics and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Cyclerion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclerion Therapeutics has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Cyclerion Therapeutics go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Cyclerion Therapeutics
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 1.03 times more return on investment than Cyclerion Therapeutics. However, SAB Biotherapeutics is 1.03 times more volatile than Cyclerion Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Cyclerion Therapeutics is currently generating about 0.04 per unit of risk. If you would invest 7.20 in SAB Biotherapeutics on September 3, 2024 and sell it today you would lose (0.45) from holding SAB Biotherapeutics or give up 6.25% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 90.0% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Cyclerion Therapeutics
Performance |
| Timeline |
| SAB Biotherapeutics |
| Cyclerion Therapeutics |
SAB Biotherapeutics and Cyclerion Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Cyclerion Therapeutics
The main advantage of trading using opposite SAB Biotherapeutics and Cyclerion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Cyclerion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclerion Therapeutics will offset losses from the drop in Cyclerion Therapeutics' long position.| SAB Biotherapeutics vs. DiaMedica Therapeutics | SAB Biotherapeutics vs. Lyra Therapeutics | SAB Biotherapeutics vs. Centessa Pharmaceuticals PLC |
| Cyclerion Therapeutics vs. Kronos Bio | Cyclerion Therapeutics vs. Larimar Therapeutics | Cyclerion Therapeutics vs. Addex Therapeutics | Cyclerion Therapeutics vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |